Category: Prescription Drugs
Europe Prescription Drugs
-
Europe Neuroblastoma Drugs Market Size study, by Type (Chemotherapy, Immunotherapy, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Online, Offline), and Country Forecasts 2022-2032
... million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.96% over the forecast period 2024-2032. Neuroblastoma is a cancer primarily occurred in young children below five years old, ... Read More
-
North America & Europe Epilepsy Market Research Report Information Forecast to 2032 Based on Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, Canada, Europe).
... (US, Canada, Europe) It is projected that the epilepsy market in North America and Europe would increase at a strong rate throughout the study period, with a compound annual growth rate of 8.18%. Recurrent seizures ... Read More
-
Europe Cold Sore Treatment (for HSV 1 Virus) Market
... the CAGR of 6.2% in the forecast period of 2024 to 2031. Market Segmentation Europe Cold Sore Treatment (for HSV 1 Virus) Market, By Treatment Type (Medications, Applied Products, Cold Sore Patches, and Others(Non Medicated ... Read More
-
Europe Ophthalmic Drugs Market 2023-2030
... United Kingdom, Poland, Germany, and the Rest of Europe are studied in this report. Germany is experiencing positive growth in the ophthalmic market due to an increase in age-related macular degeneration, cataracts, and other eye ... Read More
-
Rx/Reimbursement Adult Incontinence in Austria
... raw material, production and transport costs forced manufacturers to increase the average unit prices of their products. Indeed, the category saw fairly flat performance in volume terms, as strict regulations continued to dampen demand. In ... Read More
-
Rx/Reimbursement Adult Incontinence in Switzerland
... visiting their doctors more frequently in 2023, in an attempt to save some money by obtaining prescriptions for incontinence products. Value growth was partly driven by the increased costs of production and effects of a ... Read More
-
Rx/Reimbursement Adult Incontinence in Germany
... growth decreased marginally, in a similar trend to previous years. The demand for rx/reimbursement adult incontinence in Germany is primarily driven by the country's ageing population, but also by women experiencing post-partum leakage issues. As ... Read More
-
Intravenous Solutions Market, by Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringers, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), by Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), by Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), by End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... than 250ml) and Small Volume Bags (less than 250ml)), by Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), by End User (Hospitals, Clinics, Ambulatory Surgery Centers, ... Read More
-
Urinary Tract Infection Therapeutic Market, By Drug (Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, and Other Drugs), By Indication (Complicated UTI, Uncomplicated UTI, and Other Indications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 A urinary tract infection (UTI) is an infection in any part of the urinary system. Women are at ... Read More
-
Rx/Reimbursement Adult Incontinence in Slovenia
... more individuals are seeking treatment in hospitals for incontinence issues. Additionally, heightened awareness has led to a growing number of younger individuals experiencing incontinence problems seeking medical attention. Postpartum women, in particular, are contributing to ... Read More
-
Rx/Reimbursement Adult Incontinence in Latvia
... often require assistance, including the use of adult incontinence products. As the elderly population grows, there is a corresponding surge in the demand for prescriptions and reimbursements for adult incontinence products, reflecting the essential role ... Read More
-
Rx/Reimbursement Adult Incontinence in Italy
... so-called “Community Health Houses” will be further decreased and, according to plans, this will be compensated by at-home assistance to patients and telemedicine. The aim of “Community Health Houses” is to offer nearby healthcare to ... Read More
-
Rx/Reimbursement Adult Incontinence in the Netherlands
... online, despite insurance reimbursement options available in the country. Retail e-commerce gives consumers the freedom to select their preferred brands and types. Moreover, under the RX/reimbursement model, basic incontinence pads and adult nappies/diapers are usually ... Read More
-
Rx/Reimbursement Adult Incontinence in Estonia
... associated with limited funding through Rx channels. Moderate/heavy adult incontinence products remained the preferred choice for consumers diagnosed with more severe incontinence issues, contributing to the overall positive performance of the product area. Euromonitor International's ... Read More
-
Rx/Reimbursement Adult Incontinence in France
... There was a small deceleration in the first year of the COVID-19 pandemic as consumers were more reluctant to go to the doctor, viewing surgeries or hospitals as a prime place to contract the virus. ... Read More
-
Europe Breast Cancer Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies)
... Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies) The ... Read More
-
Pharmaceutical Market in Denmark 2024-2028
... market in Denmark provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Global Menopause Treatment Market, By Treatment Type (Hormone Therapy, Non-hormonal Therapy, Others), By Route of Administration (Oral, Topical, Parenteral, Vaginal, Others), By Form (Tablets, Creams, Patches , Pessaries, Injections, Others), By Indication (Perimenopause, Menopause, Postmenopause), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Stores, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Stores, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The global menopause treatment market was valued US$ 15.33 Bn ... Read More
-
Global Antibiotic Resistance Market, By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Others), By Disease (cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The ... Read More
-
UK & Australia Dry Mouth Relief Market Research Report Forecast to 2032
... but rather a complication of several conditions, such as smoking, mouth bleeding, radiation damage to the head and neck, and adverse effects of specific medications. There are a variety of ways to treat a dry ... Read More
-
Finland Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... Medicines Agency, data updated in 2022, the COVID-19 pandemic in Finland did not significantly impacted medication availability. To avoid complications even if the situation persists, Finnish healthcare and pharmaceutical operators collaborated closely to prevent shortages. ... Read More
-
Epilepsy Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, ... Read More
-
Overweight Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Awareness and Strategic Partnerships Drive Demand for Overweight Treatment Solutions The global overweight treatment market is witnessing robust growth, fueled by a combination of factors including increased awareness among the morbidly obese population, strategic collaborations ... Read More
-
Statins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Dominates the Market, with the United States Leading in Statin Usage • Rising Obesity and Cardiovascular Disease Cases Boost Demand for Statins Worldwide The global statins market is on a steady growth trajectory and is ... Read More
-
Treatment Syndromes Dementia Movement Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) Leading Pharmaceutical Companies Aim to Address Rising Incidence of Cognitive Defects The global market for the treatment of syndromes related to dementia and movement disorders has witnessed remarkable growth in recent years, as ... Read More
Research Assistance
